Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

- Sosman, Jeffery A., Kim, Kevin B., Hersey, Peter, Kefford, Richard, Lawrence, Donald, Puzanov, Igor, Lewis, Karl D., Amaravadi, Ravi K., Chmielowski, Bartosz, Lawrence, H. Jeffrey, Shyr, Yu, Ye, Fei, Schuchter, Lynn, Gonzalez, Rene, Pavlick, Anna C., Weber, Jeffrey S., McArthur, Grant A., Hutson, Thomas E., Moschos, Stergios J., Flaherty, Keith T.

Targeting apoptotic pathways in melanoma

- Hersey, Peter, Zhang, Xu Dong

The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells

- Tseng, Hsin-Yi, Chen, Li Hua, Ye, Yan, Tay, Kwang Hong, Jiang, Chen Chen, Guo, Su Tang, Jin, Lei, Hersey, Peter, Zhang, Xu Dong

Dual processing of FAT1 cadherin protein by human melanoma cells generates distinct protein products

- Sadeqzadeh, Elham, de Bock, Charles E., Boyd, Andrew W., Burns, Gordon F., Thorne, Rick F., Zhang, Xu Dong, Shipman, Kristy L., Scott, Naomi M., Song, Chaojun, Yeadon, Trina, Oliveira, Camila S., Jin, Boquan, Hersey, Peter

MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720

- Jiang, Chen Chen, Lai, Fritz, Thorne, Rick F., Yang, Fan, Liu, Hao, Hersey, Peter, Zhang, Xu Dong

MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma

- Jin, Lei, Hu, Wang Lai, Hersey, Peter, Zhang, Xu Dong, Wu, Mian, Jiang, Chen Chen, Wang, Jia Xu, Han, Chuan Chun, Chu, Ping, Zhang, Lin Jie, Thorne, Rick F., Wilmott, James, Scolyer, Richard A.

P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation

- Avery-Kiejda, Kelly A., Bowden, Nikola A., Hersey, Peter, Croft, Amanda J., Scurr, Lyndee L., Kairupan, Carla F., Ashton, Katie A., Talseth-Palmer, Bente A., Rizos, Helen, Zhang, Xu D., Scott, Rodney J.

The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers

- Wilmott, James S., Zhang, Xu Dong, Hersey, Peter, Scolyer, Richard A.

A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy

- Kefford, Richard F., Clingan, Philip R., Brady, Benjamin, Ballmer, Andrea, Morganti, Adele, Hersey, Peter

Contrasting effects of Nutlin-3 on TRAIL- and Docetaxel-induced Apoptosis due to upregulation of TRAIL-R2 and Mcl-1 in human melanoma cells

- Tseng, Hsin-Yi, Jiang, Chen Chen, Croft, Amanda, Thorne, Rick Francis, Yang, Fan, Liu, Hao, Hersey, Peter, Zhang, Xu Dong

Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins

- Zhuang, Liquing, Scolyer, Richard A., Murali, Rajmohan, McCarthy, Stanley W., Zhang, Xu Dong, Thompson, John F., Hersey, Peter

Nucleotide excision repair gene expression after cisplatin treatment in melanoma

- Bowden, Nikola A., Ashton, Katie A., Kiejda, Kelly A., Zhang, Xu Dong, Hersey, Peter, Scott, Rodney J.

Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

- Kirkwood, John M., Lorigan, Paul, Hersey, Peter, Hauschild, Axel, Robert, Caroline, McDermott, David, Marshall, Margaret A., Gomez-Navarro, Jesus, Liang, Jane Q., Bulanhagui, Cecile A.

Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma

- Eisen, Tim, Trefzer, Uwe, Hamilton, Anne, Hersey, Peter, Millward, Michael, Knight, Robert D., Jungnelius, Jarl U., Glaspy, John

2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2

- Liu, Hao, Jiang, Chen Chen, Lavis, Christopher J., Croft, Amanda, Dong, Li, Tseng, Hsin-Yi, Yang, Fan, Tay, Kwang Hong, Hersey, Peter, Zhang, Xu Dong

Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma

- Zhuang, Liquing, Scolyer, Richard A., Lee, C. Soon, McCarthy, Stanley W., Cooper, Wendy A., Zhang, Xu Dong, Thompson, John F., Hersey, Peter

Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells

- Jiang, Chen Chen, Mao, Zhi Gang, Avery-Kiejda, Kelly A., Hersey, Peter, Zhang, Xu Dong

Human melanoma cells under endoplasmic reticulum stress acquire resistance to microtubule-targeting drugs through XBP-1-mediated activation of Akt

- Jiang, Chen Chen, Yang, Fan, Thorne, Rick F., Zhu, Bi Ke, Hersey, Peter, Zhang, Xu Dong

Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax

- Jiang, Chen Chen, Wroblewski, David, Yang, Fan, Hersey, Peter, Zhang, Xu Dong

Inhibition of MEK blocks GRP78 up-regulation and enhances apoptosis induced by ER stress in gastric cancer cells

- Zhang, Lin Jie, Chen, Si, Wu, Pin, Hu, Chun Song, Thorne, Rick F., Luo, Chang Ming, Hersey, Peter, Zhang, Xu Dong